NCT02139020 Collection of Plasma Samples for Squamous Cell Carcinoma of the Head and Neck Patients
| NCT ID | NCT02139020 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
| Condition | Squamous Cell Carcinoma of the Head and Neck |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2013-02 |
| Primary Completion | 2033-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2013-02 with a primary completion date of 2033-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators will collect plasma samples at baseline, during treatment, and at progression.
Eligibility Criteria
Inclusion Criteria: * patients treated with radiation therapy and cetuximab according to Bonner et al * patients treated with cetuximab in combination with chemotherapy according to Vermorken et al. * patients treated with a molecular targeted agent as a part of a clinical study Exclusion Criteria: * patients with another type of head and neck cancer * patients non treated with targeted therapies
Contact & Investigator
Jean-Pascal Machiels, MD, PhD
PRINCIPAL INVESTIGATOR
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Frequently Asked Questions
Who can join the NCT02139020 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Squamous Cell Carcinoma of the Head and Neck. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02139020 currently recruiting?
Yes, NCT02139020 is actively recruiting participants. Contact the research team at jean-pascal.machiels@uclouvain.be for enrollment information.
Where is the NCT02139020 trial being conducted?
This trial is being conducted at Ottignies, Belgium, Charleroi, Belgium, Haine-Saint-Paul, Belgium, Liège, Belgium and 1 additional location.
Who is sponsoring the NCT02139020 clinical trial?
NCT02139020 is sponsored by Cliniques universitaires Saint-Luc- Université Catholique de Louvain. The principal investigator is Jean-Pascal Machiels, MD, PhD at Cliniques universitaires Saint-Luc- Université Catholique de Louvain. The trial plans to enroll 400 participants.